Does ^99m Tc-tilmanocept, as next generation radiotracer, meet with the requirements for improved sentinel node imaging?

Autor: Rietbergen DD; Nuclear Medicine Section & Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, Netherlands. Electronic address: D.D.D.Rietbergen@lumc.nl., Pereira Arias-Bouda LM; Nuclear Medicine Section & Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, Netherlands; Department of Nuclear Medicine, Alrijne Ziekenhuis, Leiderdorp, Netherlands., van der Hage J; Department of Surgery, Department of Radiology, Leiden University Medical Centre, Netherlands., Valdés Olmos RA; Nuclear Medicine Section & Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, Netherlands; Department of Radiology and Nuclear Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.

Publikováno v: Revista espanola de medicina nuclear e imagen molecular [Rev Esp Med Nucl Imagen Mol (Engl Ed)] 2021 Sep-Oct; Vol. 40 (5), pp. 275-280. Date of Electronic Publication: 2020 Dec 02.

Interventional nuclear medicine: a focus on radioguided intervention and surgery.

Autor: Rietbergen DD; Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, the Netherlands., VAN Oosterom MN; Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, the Netherlands.; Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Kleinjan GH; Department of Urology, Leiden University Medical Center, Leiden, the Netherlands., Brouwer OR; Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, the Netherlands.; Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Valdes-Olmos RA; Section of Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands., VAN Leeuwen FW; Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, the Netherlands.; Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Buckle T; Department of Radiology, Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, the Netherlands - t.buckle@lumc.nl.; Department of Urology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.

Publikováno v: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2021 Mar; Vol. 65 (1), pp. 4-19. Date of Electronic Publication: 2021 Jan 26.

Hybrid radioguided occult lesion localization (hybrid ROLL) of (18)F-FDG-avid lesions using the hybrid tracer indocyanine green-(99m)Tc-nanocolloid.

Autor: KleinJan GH; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands; Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Brouwer OR; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands; Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Mathéron HM; Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Rietbergen DD; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands; Section Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Valdés Olmos RA; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands; Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Section Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Wouters MW; Department of Surgery, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van den Berg NS; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands; Department of Head and Neck Surgery & Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van Leeuwen FW; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands; Department of Head and Neck Surgery & Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: F.W.B.van_Leeuwen@lumc.nl.

Publikováno v: Revista espanola de medicina nuclear e imagen molecular [Rev Esp Med Nucl Imagen Mol] 2016 Sep-Oct; Vol. 35 (5), pp. 292-7. Date of Electronic Publication: 2016 May 09.

Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.

Autor: Verbeek FP; Departments of *Surgery and †Radiology, Nuclear Medicine Section and Interventional Molecular Imaging Laboratory, and Department of ‡Gynecology and Obstetrics, Leiden University Medical Center, Leiden, the Netherlands; and §Department of Radiology and ∥Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA., Tummers QR, Rietbergen DD, Peters AA, Schaafsma BE, van de Velde CJ, Frangioni JV, van Leeuwen FW, Gaarenstroom KN, Vahrmeijer AL

Publikováno v: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2015 Jul; Vol. 25 (6), pp. 1086-93.

Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from "open and see" to "see and open".

Autor: Valdés Olmos RA; Diagnostic Oncology, Nuclear Medicine Department Netherlands Cancer Institute Antoni van Leewenhoek Hospital Amsterdam, The Netherlands - r.valdes@nki.nl., Rietbergen DD, Vidal-Sicart S, Manca G, Giammarile F, Mariani G

Publikováno v: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2014 Jun; Vol. 58 (2), pp. 127-39.